Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0001209191-23-007376

CEO and President sold 120,000 shares at $11.01 ($1,320,696)

From the SEC's structured data for this filing

Trades in this filing

Kumar Neil · CEO and President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-03 Sale : show line 1 in the form −120,000 $11.01 $1,320,696 1,372,722 I
Open-market sales · 120,000 sh · avg $11.01 · $1,320,696
Loading xslF345X03/doc4.xml…